Seeing Is Believing
ENTX is currently covered by 1 analysts with an average price target of $6.92. This is a potential upside of $5.29 (324.54%) from yesterday's end of day stock price of $1.63.
Entera Bio Ltd's activity chart (see below) currently has 19 price targets and 16 ratings on display. The stock rating distribution of ENTX is 100% BUY.
Highest price target for ENTX is $2, Lowest price target is $2.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 18-Mar-2025. First documented stock forecast 03-Aug-2018.
Currently out of the existing stock ratings of ENTX, 1 are a BUY (100%).
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 13-May-2024
9 months 28 days ago
(18-Mar-2025)
0/3 (0%)
$7.99 (397.51%)
Buy
Since 24-Jun-2021
$5
$3.4 (212.50%)
$6
3 years 5 months 27 days ago
(19-Jul-2022)
0/4 (0%)
$3.55 (244.83%)
Buy
Since 22-Mar-2021
$9
$7.4 (462.50%)
$12
3 years 9 months 24 days ago
(22-Mar-2022)
0/2 (0%)
$6.5 (260.00%)
Buy
Since 03-Aug-2018
$10
$8.4 (525.00%)
$8
4 years 10 months 3 days ago
(12-Mar-2021)
0/3 (0%)
$3.1 (44.93%)
What is ENTX (Entera Bio Ltd) average time for price targets to be met?
Which analyst has the current highest performing score on ENTX (Entera Bio Ltd) with a proven track record?
Which analyst has the current lower performing score on ENTX (Entera Bio Ltd) with a proven track record?
Which analyst has the most public recommendations on ENTX (Entera Bio Ltd)?
Which analyst is the currently most bullish on ENTX (Entera Bio Ltd)?
Which analyst is the currently most reserved on ENTX (Entera Bio Ltd)?